Cargando…
Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?
Lung cancer is still diagnosed during the advanced stage of the disease and most patients do not have the opportunity for surgical treatment, despite the new diagnostic equipment that has been made available in recent years, such as the radial and linear endobronchial ultrasound (EBUS) and electroma...
Autores principales: | ZAROGOULIDIS, Paul, LAMPAKI, Sofia, CHINELIS, Panos, LAZARIDIS, George, BAKA, Sofia, RAPTI, Aggeliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346303/ https://www.ncbi.nlm.nih.gov/pubmed/28293661 |
Ejemplares similares
-
Lung Cancer and Eye Metastases
por: Lampaki, Sofia, et al.
Publicado: (2014) -
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
por: Lampaki, Sofia, et al.
Publicado: (2015) -
Targeted Lung Cancer Treatments and Eye Metastasis
por: ZAROGOULIDIS, Paul, et al.
Publicado: (2017) -
Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016) -
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
por: Pitsiou, Georgia, et al.
Publicado: (2014)